154 related articles for article (PubMed ID: 32007357)
21. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
[TBL] [Abstract][Full Text] [Related]
22. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
23. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
Hsieh CC; Shyr YM; Liao WY; Chen TH; Wang SE; Lu PC; Lin PY; Chen YB; Mao WY; Han HY; Hsiao M; Yang WB; Li WS; Sher YP; Shen CN
Oncotarget; 2017 Jan; 8(5):7691-7709. PubMed ID: 28032597
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of Rab23 inhibits the invasion and motility of pancreatic duct adenocarcinoma.
Cai ZZ; Xu LB; Cai JL; Wang JS; Zhou B; Hu H
Genet Mol Res; 2015 Mar; 14(1):2707-15. PubMed ID: 25867419
[TBL] [Abstract][Full Text] [Related]
25. COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma.
You N; Li J; Gong Z; Huang X; Wang W; Wang L; Wu K; Zheng L
Mol Carcinog; 2017 Feb; 56(2):607-624. PubMed ID: 27350032
[TBL] [Abstract][Full Text] [Related]
26. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
[TBL] [Abstract][Full Text] [Related]
28. KANSL2 and MBNL3 are regulators of pancreatic ductal adenocarcinoma invasion.
Oladimeji PO; Bakke J; Wright WC; Chen T
Sci Rep; 2020 Jan; 10(1):1485. PubMed ID: 32001790
[TBL] [Abstract][Full Text] [Related]
29. MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity.
Liang E; Lu Y; Shi Y; Zhou Q; Zhi F
Oncogene; 2020 Oct; 39(41):6437-6450. PubMed ID: 32879444
[TBL] [Abstract][Full Text] [Related]
30. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
31. ProNGF siRNA inhibits cell proliferation and invasion of pancreatic cancer cells and promotes anoikis.
Xu J; Song J; Yang X; Guo J; Wang T; Zhuo W
Biomed Pharmacother; 2019 Mar; 111():1066-1073. PubMed ID: 30841420
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model.
Takakura K; Shibazaki Y; Yoneyama H; Fujii M; Hashiguchi T; Ito Z; Kajihara M; Misawa T; Homma S; Ohkusa T; Koido S
PLoS One; 2015; 10(12):e0142981. PubMed ID: 26642349
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
34. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
35. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
36. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
Zhou S; da Silva SD; Siegel PM; Philip A
Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
[TBL] [Abstract][Full Text] [Related]
37. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
38. Dysbindin promotes pancreatic ductal adenocarcinoma metastasis by activating NF-κB/MDM2 via miR-342-3p.
Zhu D; Zheng S; Fang C; Guo X; Han D; Tang M; Fu H; Jiang M; Xie N; Nie Y; Yao X; Chen Y
Cancer Lett; 2020 May; 477():107-121. PubMed ID: 32120026
[TBL] [Abstract][Full Text] [Related]
39. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
40. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.
Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X
Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
